Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Immobile Patients”

127 trials

Showing 20 of 127 results

Not applicableStudy completedNCT05434377
What this trial is testing

Fixed Dose Versus Serum Level-Based Titration Regimen of Vitamin D Supplementation in Dialysis Patients

Who this might be right for
Vitamin D DeficiencyEnd Stage Renal Disease
Chulalongkorn University 78
Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Large-scale testing (Phase 3)Study completedNCT02796677
What this trial is testing

AMPLIFY - D6571C00001 Duaklir USA Phase III Study

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,595
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Large-scale testing (Phase 3)Study completedNCT01559116
What this trial is testing

Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 219
Testing effectiveness (Phase 2)Study completedNCT02030535
What this trial is testing

Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 53
Testing effectiveness (Phase 2)Looking for participantsNCT04908228
What this trial is testing

Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Paolo Ghia 53
Large-scale testing (Phase 3)UnknownNCT05890638
What this trial is testing

Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
COPD
Neutec Ar-Ge San ve Tic A.Ş 74
Testing effectiveness (Phase 2)Ended earlyNCT02078960
What this trial is testing

Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 10
Large-scale testing (Phase 3)Study completedNCT01964352
What this trial is testing

Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 813
Not applicableUnknownNCT05114434
What this trial is testing

Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)

Who this might be right for
COPD, Chronic Obstructive Pulmonary Disease
University of Parma 40
Early research (Phase 1)Study completedNCT01703845
What this trial is testing

Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 32
Large-scale testing (Phase 3)WithdrawnNCT01393145
What this trial is testing

Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseCOPD
Ache Laboratorios Farmaceuticos S.A.
Post-approval studies (Phase 4)Looking for participantsNCT06531798
What this trial is testing

Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Moderate to Severe COPD
AstraZeneca 150
Post-approval studies (Phase 4)Study completedNCT00527826
What this trial is testing

Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 214
Post-approval studies (Phase 4)Study completedNCT04431518
What this trial is testing

Pharmacokinetics of JULUCA in Hemodialysis

Who this might be right for
HIV/AIDSESRD
Indiana University 8
Post-approval studies (Phase 4)Study completedNCT00530842
What this trial is testing

Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 344
Large-scale testing (Phase 3)Study completedNCT01525615
What this trial is testing

Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 404
Post-approval studies (Phase 4)Study completedNCT01329029
What this trial is testing

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,945
Testing effectiveness (Phase 2)Study completedNCT00626522
What this trial is testing

Aclidinium/Formoterol Fixed Combination Dose Finding Study

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 808
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation